| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| 20/20 Biolabs, Inc. | Director | Common Stock | 31 | 19 Feb 2026 | Direct | ||
| 20/20 Biolabs, Inc. | Director | Series A-2 Preferred Stock | 0 | 19 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000121390026019424-ross-michael-a-2026-02-19 | 20/20 Biolabs, Inc. | 19 Feb 2026 | 2 | $0 | 4 | Director | 23 Feb 2026, 18:13 |
| /report/000121390026017548-ross-michael-a-2026-02-17 | 20/20 Biolabs, Inc. | 17 Feb 2026 | 0 | $0 | 3 | Director | 17 Feb 2026, 18:27 |